Pilot Validation of STELA Digital Preventive Medicine Platform for Cardiovascular Risk Reduction in Adults
ClinicalTrials.gov Studies
Summary
A pilot validation study for the STELA digital preventive medicine platform has been registered on ClinicalTrials.gov (NCT07551960) by researchers at AGEL Hospital Trinec-Podlesi in Czechia. The platform is designed to identify, quantify, and reduce modifiable cardiovascular health risk factors in adults without established cardiovascular disease through comprehensive health assessments, personalized prevention plans, and coordinated wellness interventions. The study uses the AGEL Gamification Index scoring system and involves participants undergoing extensive baseline assessments including laboratory panels, physical tests, and imaging studies.
“The STELA system is designed to identify, quantify, and reduce modifiable health risk factors in adults who have no established cardiovascular disease.”
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
This ClinicalTrials.gov registry entry documents a pilot validation study for the STELA preventive medicine platform developed at AGEL Hospital Trinec-Podlesi in Czechia. The study enrolls adults without established cardiovascular disease and uses a comprehensive assessment battery including lifestyle questionnaires, physical and functional tests, laboratory panels, and imaging studies. Participants receive an AGEL Gamification Index score and personalized prevention plans through shared decision-making with physicians.
Healthcare providers and clinical researchers interested in digital health interventions for cardiovascular prevention may reference this study design when developing similar programs. The registry entry provides a structured framework for comprehensive health risk assessment combining biochemical markers (lipid profile, insulin resistance, inflammatory markers), functional assessments (VO2max, grip strength), and imaging (coronary artery calcium scoring) with gamified digital engagement. Institutions evaluating digital health platforms for preventive medicine programs should note the multi-modal intervention approach combining e-learning, coordinated referrals, and health coaching.
Archived snapshot
Apr 28, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Pilot Validation of the STELA Preventive Medicine Platform to Reduce Modifiable Health Risk Factors in Adults (CPM-STELA)
N/A NCT07551960 Kind: NA Apr 27, 2026
Abstract
This study evaluates a comprehensive digital health platform called STELA, developed at the Center for Preventive Medicine (CPM) of AGEL Hospital Trinec-Podlesi in Czechia. The STELA system is designed to identify, quantify, and reduce modifiable health risk factors in adults who have no established cardiovascular disease.
Each participant undergoes a thorough baseline assessment including questionnaires (lifestyle, psychosocial, medical history), physical and functional tests (blood pressure, body composition via InBody, hand grip strength, cardiopulmonary exercise testing/VO2max, Functional Movement Screen), laboratory panel (lipid profile, ApoB, Lp(a), insulin resistance/HOMA-IR, hs-CRP, vitamin D3, uric acid), and imaging studies (coronary artery calcium score by CT in participants over 30 years, echocardiography, abdominal ultrasound, limited polysomnography).
All data are entered into the STELA platform, which calculates a composite AGEL Gamification Index (AGI, scored 0-100%) with visual feedback via spider and funnel charts. Based on the AGI results, a 45-minute physician consultation using shared decision-making generates a personalized prevention plan.
The intervention includes: interactive e-learning modules (nutrition, physical activity, sleep, stress management), coordinated referrals to physiotherapy, nutritional counseling, addiction services, and optional health coaching/hypnosis, automated digital reminders, a motivational telephone call at 1 month, and...
Conditions: Cardiovascular Risk Factors, Insulin Resistance, Obesity, Dyslipidemias, Metabolic Syndrome
Interventions: STELA Digital Preventive Medicine Platform, Comprehensive Preventive Health Assessment
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.